LONDON (AFP) - Anglo-Swedish pharmaceuticals giant AstraZeneca on Wednesday said it had agreed to buy French antibiotics manufacturer Novexel for 350 million dollars (244 million euros).

Related news:
Drugmaker AstraZeneca says profits jump

"AstraZeneca has agreed to acquire 100 percent of Novexel's shares for 350 million dollars in cash... and will pay up to an additional 75 million dollars to Novexel shareholders if specified development milestones are reached," said a statement.

Last Updated (Wednesday, 23 December 2009 17:14)